17 May, 2026

Stockholmsmässan, Stockholm, Sweden

ESTRO2026 MAMMOKNIFE Lunch Symposium

What to Expect

Prone Radiotherapy, Modernized

An Exclusive Satellite Symposium at ESTRO Annual Congress 2026

Join us Sunday, May 17 | 13:00 – 14:00 Lunch
Room: Viktoria | Stockholmsmassan, Stockholm, Sweden

❋ Why attend

Breast radiotherapy is evolving, but are current techniques keeping up with clinical needs?

Join leading experts for a focused, high-impact session exploring how prone positioning is being redefined to improve precision, workflow, and patient outcomes.

This is not just another lecture, it’s a discussion on where breast radiotherapy is headed next.

You’ll walk away with:

  • Insight into emerging clinical approaches and technology innovation

  • Expert perspectives from leaders shaping the future of breast cancer treatment

  • A first look at a novel solution designed to rethink the standard of care

❋ Featured Speakers

Michael Dominello, DO Karmanos Cancer Institute, USA (Chair & Lead Speaker)

Stefan Ueltzhöffer
CEO - gKteso GmbH, Germany 

Michael Teicher
CEO - MAMMOKNIFE, USA

❋ Event Details

This satellite symposium will take place onsite during the ESTRO Annual Congress 2026 in Stockholm, held in Room Viktoria at the congress venue.

Scroll down to view the full agenda and featured speaker line-up.

Please note that seating is limited, and refreshments will be available on a first-come, first-served basis. We encourage early arrival to ensure your participation. We look forward to welcoming you for an engaging session focused on advancing the future of breast radiotherapy.

Register now to reserve your seat and be part of the conversation shaping the future of breast radiotherapy.
A blurry image of a person standing in front of an audience, giving a presentation or speech in a conference room.
Agenda

Prone Radiotherapy, Reimagined

Join us for lunch. Expect a balance of thought leadership and practical relevance, with time built in for discussion so you can engage directly with the experts and explore what these advancements mean for your own clinical practice.


13:00 – 13:05

Welcome & Introduction

Michael Teicher, CEO, MAMMOKNIFE, USA 


13:05 – 13:30

Prone Radiotherapy Modernized:
Clinical Rationale & Unmet Needs

Michael Dominello, DO
Karmanos Cancer Institute, USA


13:30 – 13:45

Rethinking Prone Breast Radiotherapy:
The MAMMOKNIFE Approach

Stefan Ueltzhöffer, CEO
gKteso GmbH, Germany


13:45 – 13:55

Open Discussion & Expert Perspectives

Led by Michael Dominello, DO  


13:55 – 14:00

Closing Remarks 

Michael Teicher, CEO, MAMMOKNIFE, USA 


Register today